[Information provided by:
ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]
|NCT02964416 : Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery|
|Ages||Min: 18 Years Max: 65 Years|
- Patients with craniotomy for supratentorial tumors under general anesthesia
- American Society of Anaesthesiologists (ASA) 2 and stable ASA 3 patients
- Elective surgery
- Patients with Glasgow Coma Scale (GCS) 15/15
- Patients with a history of allergy or hypersensitivity to tramadol.
- History of epilepsy or convulsions due to any reason.
- Chronic usage of analgesic drugs.
- Patients using monoamine oxidase inhibitors.
- Patients with clinical signs of raised ICP.
- Obesity (women with a body mass index >35 kg/m2 or men with a body mass index >42
- Language barrier.
- Patients taking B-blockers or Ca channel blockers.
- Patients above 65 years of age ( Physiology difference)
|Links||Permanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02964416
| Link to official Clinicaltrials.gov listing